Bausch + Lomb Corporation

Bausch + Lomb Corporation is a global eye health company dedicated to helping people see better to live better. Founded in 1853, it stands as one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company's corporate headquarters are located in Vaughan, Ontario, Canada, with a significant U.S. headquarters in Bridgewater, New Jersey.

Bausch + Lomb operates through three primary segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment offers a wide range of contact lenses, lens care products, and over-the-counter eye health products such as eye drops and vitamins, including brands like Biotrue, PreserVision, and Lumify. Its Pharmaceuticals segment provides proprietary and generic treatments for various eye conditions, including glaucoma, dry eyes, and post-operative care, with products like XIIDRA and Vyzulta. The Surgical segment focuses on medical device equipment, consumables, and technologies for cataract, corneal, vitreous, and retinal eye conditions, featuring intraocular lenses and advanced surgical systems.

Led by CEO and Chairman Brent Saunders, Bausch + Lomb maintains a leading position in the eye care industry, competing with major players globally. The company recently reported strong first-quarter 2026 financial results, with revenue reaching $1.244 billion, an increase of 9% year-over-year, and subsequently raised its full-year 2026 revenue guidance. Bausch + Lomb continues to invest in innovation, with plans for new daily disposable silicone hydrogel multifocal and toric contact lenses in 2026, and has recently launched the enVista Envy full range of vision intraocular lens in Europe. The company is a subsidiary of Bausch Health Companies Inc., which holds an 88% ownership stake.